HTFL

HEARTFLOW INC

• Simply Wall St·36m ago

  Assessing HeartFlow (HTFL) Valuation After Mixed Price Performance And Rich Revenue Multiple

• TipRanks·2d ago

  Analysts Are Bullish on These Healthcare Stocks: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA)

• Reuters·5d ago

  Heartflow CMO Campbell Rogers disposes of common shares worth 1.6 million

• Simply Wall St·04/01 23:31

  Assessing HeartFlow (HTFL) Valuation After Recent Share Price Weakness

• TipRanks·03/26 12:42

  J.P. Morgan Sticks to Its Buy Rating for HeartFlow, Inc. (HTFL)

• Reuters·03/23 22:34

  Heartflow Chief Medical Officer Campbell Rogers disposes of USD 1,658,000 in common shares

• Simply Wall St·03/21 18:06

  HeartFlow’s AI Data And New Tools Reframe Coronary Disease Investment Story

• Reuters·03/20 22:25

  Heartflow CEO John C.M. Farquhar disposes of USD 243,125 in common shares

• Simply Wall St·03/19 22:17

  HeartFlow (HTFL) Revenue Growth Story Confronts Ongoing EPS Losses In Q4 2025

• Dow Jones·03/19 20:26

  HeartFlow Price Target Cut to $35.00/Share From $40.00 by JP Morgan

• Dow Jones·03/19 20:26

  HeartFlow Is Maintained at Overweight by JP Morgan

• Benzinga·03/19 20:16

  JP Morgan Maintains Overweight on HeartFlow, Lowers Price Target to $35

• Dow Jones·03/19 19:00

  HeartFlow Price Target Raised to $43.00/Share From $40.00 by Canaccord Genuity

• Dow Jones·03/19 19:00

  HeartFlow Is Maintained at Buy by Canaccord Genuity

• Benzinga·03/19 18:51

  Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $43